DFV890: a new oral NLRP3 inhibitor—tested in an early phase 2a randomised clinical trial in patients with COVID-19 pneumonia and impaired respiratory function
Ildikó Madurka, Alexander Vishnevsky, Joan B. Soriano, Stephanus J. Gans, Danilo Joel Salazar Ore, Adrián Rendón, Charlotte Suppli Ulrik, Sushma Bhatnagar, Srikanth V. Krishnamurthy, Kirsten Mc Harry, Tobias Welte, Alberto Alfredo Fernandez, Beata Mehes, Karin Meiser, Ewa Gatlik, Ülrike Sommer, G. Junge, Ederlon Rezende, Study group, Alberto Alfredo Fernandez, Ana Maria Bagu, Florencia Heredia Amido, Maria Belen Costa, Jorge Alejandro Brigante, Gaston Franco, Nadia Ahmed, Natalia Zerega, Marcelo Rodrigues Bacci, Caio César Ferreira Fernandes, Henrique Gitti Ragognete, Ederlon Rezende, Caio Vinicius Gouvêa Jaoude, Ellen Pierre de Olivera, Vania Quinato Malacize, Claudio Stadnik, Eduarda Annoni Ramos, Graziela Regina Kist, Gynara Rezende Barbosa, Henrique Filik, Sabrina Nalin, Charlotte Suppli Ulrik, Casper Tidemandsen, Kjell Erik Julius Håkansson, Thomas Benfield, Karen Brorup Pedersen, Tobias Welte, Marcus Bachman, Mathias Stoll, Ilona Olzik, Natascha Scharf, Nicole Shearman, Isabell Pink, Anna Frey, Petra Schulze, Cyrus Sayehli, Dirk Weismann, Hartwig Klinker, Maria-Elisabeth Goebeler, Lars S. Maier, Florian Geismann, Frank Hanses, Judith Zeller, Julian Hupf, Matthias Lubnow, Sabine Sag, Sarah Ripfel, Steffen Pabel, Stilla Bauernfeind, Ulf Leisner, Florian Hitzenbichler, Ildikó Madurka, Dora Iharos, Krisztina Kormosoi Toth, Maria Hejja, Tamas Esze, Sushma Bhatnagar, Anant Mohan, Anuja Pandit, Balbir Kumar, Brajesh Kumar Ratre, Pawan Tiwari, Ram Singh, Saurabh Vig, Shweta Bhopale, S. Bhan, Akshay Budhraja, Ankit Agrawal, Srikanth V. Krishnamurthy, Ambika Srikanth, Kalaiyamishan Kaneesan, Mauila Raghavan Jaymohan Unnithan, Nagarajan Srinivasan, Nandagopal Velayuthaswamy, Senthil Kumar Mothu Gounder, Venkatraman Vaidyanathan, Amitabha Saha, Abhishek Bhattacharjee, Avijatri Datta, Adrián Rendón, Adrián Camacho Ortiz